SCHEMBL16684307

SCHEMBL16684307

CC1(C)OC2OC(COC(=O)c3ccccc3)C(=O)[C@@H]2O1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.60
HPGD P15428 1/20 0.46
MAPK1 P28482 2/20 0.45
POLB P06746 1/20 0.45
GAA P10253 1/20 0.45
NPSR1 Q6W5P4 1/20 0.45
CES2 O00748 1/20 0.43
PPM1B O75688 1/20 0.40
LMNA P02545 1/20 0.39
PTPN1 P18031 1/20 0.39
ACP1 P24666 1/20 0.39
CDC25B P30305 1/20 0.39
CHRNB2 P17787 1/20 0.39
CHRNA5 P30532 1/20 0.39
CHRNA7 P36544 1/20 0.39
CHRNA4 P43681 1/20 0.39
NPC1 O15118 1/20 0.39
TDP1 Q9NUW8 2/20 0.38
TSHR P16473 1/20 0.38
HIF1A Q16665 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14356276 1.00 ALDH1A1 (0.60) ALDH1A1HPGDMAPK1POLBGAA
SCHEMBL11519883 1.00 ALDH1A1 (0.60) ALDH1A1HPGDMAPK1POLBGAA
SCHEMBL13010080 1.00 ALDH1A1 (0.60) ALDH1A1HPGDMAPK1POLBGAA
SCHEMBL13672341 1.00 ALDH1A1 (0.60) ALDH1A1HPGDMAPK1POLBGAA
SCHEMBL14565297 1.00 ALDH1A1 (0.60) ALDH1A1HPGDMAPK1POLBGAA
SCHEMBL4244870 1.00 ALDH1A1 (0.60) ALDH1A1HPGDMAPK1POLBGAA
SCHEMBL12556315 1.00 ALDH1A1 (0.60) ALDH1A1HPGDMAPK1POLBGAA
SCHEMBL7850077 1.00 ALDH1A1 (0.60) ALDH1A1HPGDMAPK1POLBGAA
SCHEMBL22915735 0.86 ALDH1A1 (0.59) ALDH1A1HPGDMAPK1POLBGAA
SCHEMBL14580144 0.84 ALDH1A1 (0.57) ALDH1A1HPGDMAPK1POLBGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2332952-B1 Modified 2' and 3'-nucleoside prodrugs for treating flaviridae infections IDENIX PHARMACEUTICALS INC (US) 2015-04-29 EP disclosed